Literature DB >> 8814711

Thyroid cancer: a review of treatment and follow-up.

L Vini1, C Harmer, V R McCready.   

Abstract

The importance of thyroid cancers far exceeds their frequency, since they are uncommon tumours accounting for only 1% of all malignancies and for even smaller proportion of cancer deaths (0.2%). A variety of distinct tumour types arise in the thyroid gland, with variable natural histories resulting from different rates of growth and biological aggressiveness. The long natural history of the majority of thyroid neoplasms imposes a commitment for long-term follow-up and stresses the importance of planning treatment so as to avoid delayed complications that impair the quality of life of patients. The management of thyroid cancer is multidisciplinary, requiring consultation and active intervention by surgeons, endocrinologists and radiotherapists. Surgery is of paramount importance in the successful eradication of the tumours while radioiodine offers a unique therapeutic approach. Treatment must be strongly influenced by consideration of prognostic variables.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814711     DOI: 10.1007/bf03165047

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  46 in total

1.  Chemotherapy for thyroid cancer.

Authors:  P J Hoskin; C Harmer
Journal:  Radiother Oncol       Date:  1987-11       Impact factor: 6.280

2.  External radiotherapy and radionuclide in the treatment of thyroid cancer.

Authors:  M Tubiana
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

3.  External radiotherapy and radioiodine in the treatment of 359 thyroid cancers.

Authors:  M Tubiana; J Lacour; J P Monnier; C Bergiron; R Gerard-Marchant; J Roujeau; B Bok; C Parmentier
Journal:  Br J Radiol       Date:  1975-11       Impact factor: 3.039

4.  Thyroid cancer in an iodide rich area: a histopathological study.

Authors:  E D Williams; I Doniach; O Bjarnason; W Michie
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

5.  Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil.

Authors:  S R Petursson
Journal:  Cancer       Date:  1988-11-01       Impact factor: 6.860

6.  The long-term hazards of the treatment of thyroid cancer with radioiodine.

Authors:  C J Edmonds; T Smith
Journal:  Br J Radiol       Date:  1986-01       Impact factor: 3.039

7.  Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.

Authors:  M F Saad; N G Ordonez; R K Rashid; J J Guido; C S Hill; R C Hickey; N A Samaan
Journal:  Medicine (Baltimore)       Date:  1984-11       Impact factor: 1.889

8.  Detection of activated ras oncogenes in human thyroid carcinomas.

Authors:  H G Suárez; J A Du Villard; B Caillou; M Schlumberger; M Tubiana; C Parmentier; R Monier
Journal:  Oncogene       Date:  1988-04       Impact factor: 9.867

Review 9.  Modified neck dissection in treatment of thyroid cancer: a safe procedure.

Authors:  J N Attie
Journal:  Eur J Cancer Clin Oncol       Date:  1988-02

Review 10.  The cold thyroid nodule: an analysis of diagnostic and therapeutic options.

Authors:  M E Molitch; J R Beck; M Dreisman; J E Gottlieb; S G Pauker
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

View more
  4 in total

1.  Hazard ratio for thyroid carcinoma.

Authors:  R P Spencer
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

2.  Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.

Authors:  Richard Crevenna; Georg Zettinig; Mohammad Keilani; Martin Posch; Manuela Schmidinger; Christian Pirich; Martin Nuhr; Michael Wolzt; Michael Quittan; Veronika Fialka-Moser; Robert Dudczak
Journal:  Support Care Cancer       Date:  2003-06-03       Impact factor: 3.603

3.  Thyroid carcinoma with bone metastases: a prognostic factor study.

Authors:  Karl Wu; Shen-Mou Hou; Tien-Shang Huang; Rong-Sen Yang
Journal:  Clin Med Oncol       Date:  2008-02-09

4.  Is papillary thyroid microcarcinoma an indolent tumor?: A retrospective study on 280 cases treated with radioiodine.

Authors:  Xuemei Gao; Xiao Zhang; Yajing Zhang; Wenjuan Hua; Yusufu Maimaiti; Zairong Gao
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.